✦ LIBER ✦

The prevalence of the G2019S and R1441C/G/H mutations in LRRK2 in German patients with Parkinson’s disease

✍ Scribed by J. C. Möller; I. Rissling; V. Mylius; C. Höft; K. M. Eggert; W. H Oertel

Book ID: 111065507
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 61 KB
Volume: 15
Category: Article
ISSN: 1351-5101
DOI: 10.1111/j.1468-1331.2008.02154.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuropathology of Parkinson's disease wi

Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2

✍ José-Félix Martí-Massó; Javier Ruiz-Martínez; Maria J. Bolaño; Irune Ruiz; Ana G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB

## Abstract We report the neuropathological findings in a patient with Parkinson's disease (PD) associated with Basque R1441G‐__LRRK2__/dardarin mutation. The patient was a man with disease onset at 68 years of age, with unilateral rest tremor; the Parkinsonism was well controlled with medication f

LRRK2 R1441G in Spanish patients with Pa

LRRK2 R1441G in Spanish patients with Parkinson's disease

✍ Ignacio F. Mata; Julie P. Taylor; Jennifer Kachergus; Mary Hulihan; Cecilia Huer 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 58 KB

LRRK2 G2019S and R1441G mutations associ

LRRK2 G2019S and R1441G mutations associated with Parkinson’s disease are common in the Basque Country, but relative prevalence is determined by ethnicity

✍ A. Gorostidi; J. Ruiz-Martínez; A. Lopez de Munain; A. Alzualde; J. F. Martí Mas 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 80 KB

Olfactory deficits and cardiac 123I-MIBG

Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations

✍ Javier Ruiz-Martínez; Ana Gorostidi; Estibaliz Goyenechea; Ainhoa Alzualde; Juan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

## Abstract It has been proposed that olfactory tests and metaiodobenzylguanidine cardiac scintigraphy may help diagnose idiopathic Parkinson's disease in the premotor phase. However, it is not clear what value these tests have in all patients with Parkinson's disease and, particularly, in those wh

Cognitive dysfunction in Parkinson's dis

Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2

✍ Estanga, A.; Rodriguez-Oroz, M.C.; Ruiz-Martinez, J.; Barandiaran, M.; Gorostidi 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 324 KB

Frequency and phenotypes of LRRK2 G2019S

Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease

✍ Roberta Marongiu; Daniele Ghezzi; Tamara Ialongo; Francesco Soleti; Antonio Elia 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

To evaluate the frequency of the LRRK2 G2019S mutation in Italy, we tested 1,072 probands with Parkinson's disease (PD; 822 sporadic and 250 familial): 20 patients (1.9%) carried the G2019S mutation, 11 patients (1.3%) were sporadic, and 9 (4.3%) had a positive family history. Considering only proba